FibroBiologics, Inc.
FBLGNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for FBLG. That does not mean none is planned.
Get an email about FBLG's next catalysts
Track FibroBiologics (FBLG) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
FBLG Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.63 | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
When is FibroBiologics, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for FibroBiologics, Inc. (FBLG) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track FBLG biotech catalysts?→
Add FBLG to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow FibroBiologics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.